Immatics (IMTX) Accounts Payables (2019 - 2025)
Immatics (IMTX) reported Accounts Payables of $21.9 million for Q4 2025, down 0.86% on a YoY basis from $22.1 million in Q4 2024, and down 16.78% sequentially from $26.3 million in Q3 2025.
Immatics (IMTX) Accounts Payables (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Accounts Payables data on file, last reported at $21.9 million in Q4 2025.
- For the quarter ending Q4 2025, Accounts Payables fell 0.86% year-over-year to $21.9 million; the trailing twelve-month figure through Dec 2025 stood at $21.9 million (down 0.86% YoY), and the FY2025 full-year result was $21.3 million, down 5.0% from the prior year.
- Accounts Payables fell to $21.9 million in Q4 2025, from $26.3 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $27.1 million in Q4 2023 to a low of $11.3 million in Q2 2021.
- A 5-year average of $18.5 million and a median of $19.8 million in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables jumped 103.6% in 2023 and decreased 18.46% in 2024, its largest moves.
- Tracing IMTX's Accounts Payables over 5 years: stood at $13.3 million in 2021, then advanced by 0.17% to $13.3 million in 2022, then jumped by 103.6% to $27.1 million in 2023, then slipped by 18.46% to $22.1 million in 2024, then decreased by 0.86% to $21.9 million in 2025.
- Business Quant data shows IMTX's Accounts Payables at $21.9 million in Q4 2025, $26.3 million in Q3 2025, and $21.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | 21.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.92 Mn |
| Sep 30, 2025 | 26.34 Mn |
| Jun 30, 2025 | 21.17 Mn |
| Mar 31, 2025 | 19.35 Mn |
| Dec 31, 2024 | 22.11 Mn |
| Sep 30, 2024 | 24.27 Mn |
| Jun 30, 2024 | 20.24 Mn |
| Mar 31, 2024 | 22.31 Mn |
| Dec 31, 2023 | 27.12 Mn |
| Sep 30, 2023 | 21.59 Mn |
| Jun 30, 2023 | 21.67 Mn |
| Mar 31, 2023 | 15.37 Mn |
| Dec 31, 2022 | 13.32 Mn |
| Sep 30, 2022 | 12.93 Mn |
| Jun 30, 2022 | 14.17 Mn |
| Mar 31, 2022 | 14.93 Mn |
| Dec 31, 2021 | 13.30 Mn |
| Sep 30, 2021 | 13.97 Mn |
| Jun 30, 2021 | 11.33 Mn |
| Mar 31, 2021 | 12.43 Mn |